Small Cell Lung Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Not yet recruiting
  • Small Cell Lung Cancer
  • Observation
  • (no location specified)
2022-04-07
Apr 7, 2022
N
Suspended
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
R
Completed
  • Lung Cancer, Nonsmall Cell
  • Small Cell Lung Cancer
  • FLT-PET
  • Copenhagen, Denmark
  • +1 more
2022-04-07
Apr 7, 2022
N
Recruiting
  • Carcinoma, Small Cell
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    A
    Recruiting
    • Non-Small Cell Lung Cancer
    • Small Cell Lung Cancer
    • Tucson, Arizona
    • +18 more
    2022-04-06
    Apr 6, 2022
    H
    Not yet recruiting
    • Small Cell Lung Cancer
    • IBI-322 Plus Lenvatinib
    • Changsha, Hunan, China
      Hunan Cancer hospital
    2022-03-24
    Mar 24, 2022
    S
    Recruiting
    • Small Cell Lung Cancer
    • +8 more
    • ladiratuzumab vedotin
    • Chandler, Arizona
    • +64 more
    2022-04-01
    Apr 1, 2022
    I
    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • N-803 + Pembrolizumab
    • +9 more
    • Anchorage, Alaska
    • +34 more
    2022-04-04
    Apr 4, 2022
    A
    Recruiting
    • Clear Cell Renal Cell Cancer
    • +8 more
    • La Jolla, California
    • +22 more
    2022-03-23
    Mar 23, 2022
    H
    Recruiting
    • Metastatic Solid Tumor
    • +6 more
    • Surufatinib and Tislelizumab _ Part 1
    • Surufatinib and Tislelizumab _ Part 2
    • Tucson, Arizona
    • +17 more
    2022-04-01
    Apr 1, 2022
    A
    Recruiting
    • Ovarian Cancer
    • +12 more
    • Duarte, California
    • +40 more
    2022-03-30
    Mar 30, 2022
    I
    Active, not recruiting
    • Small Cell Lung Cancer
    • Denver, Colorado
    • +118 more
    2022-03-24
    Mar 24, 2022
    C
    Recruiting
    • Small Cell Lung Cancer
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    2022-03-08
    Mar 8, 2022
    A
    Recruiting
    • Small Cell Lung Cancer
    • AMG 757
    • AMG 404
    • Lexington, Kentucky
    • +8 more
    2022-03-09
    Mar 9, 2022
    C
    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    2022-03-07
    Mar 7, 2022
    I
    Recruiting
    • Small Cell Lung Cancer
    • atezolizumab
    • Chalon-sur-Saône, France
    • +1 more
    2022-03-04
    Mar 4, 2022
    M
    Recruiting
    • Small Cell Lung Cancer
    • Basking Ridge, New Jersey
    • +6 more
    2022-03-03
    Mar 3, 2022